EIF3K and breast neoplasm: Immunofluorescence analysis of Ki67-positive (Ki67+) cells in breast tumor tissue (Fig. 4D, E) revealed that the percentage of Ki67-positive cells in the BmK-M9 treatment group was significantly lower than that in the control group.